Saturday, October 18, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

360 Finance Stock: Generous Dividend Amid Persistent Downtrend

Robert Sasse by Robert Sasse
September 2, 2025
in Analysis, Asian Markets, Crypto Stocks, Dividends, Earnings
0
360 Finance Stock
0
SHARES
179
VIEWS
Share on FacebookShare on Twitter

Shares of 360 Finance (Qfin Holdings) are approaching a significant dividend distribution while continuing to trade beneath critical technical levels. The company’s latest quarterly results delivered a mixed performance, ultimately triggering a sharp sell-off in the stock.

Technical Weakness Prevails

The stock is currently trading around $29.12, positioning it well below its key moving averages and confirming a sustained bearish trend.

  • 50-day moving average: $37.34
  • 200-day moving average: $40.31

Trading volume of 1.4 million shares last Friday also remained below the average of 2.19 million, a pattern often seen in the period preceding a dividend event.

Mixed Q2 Earnings and a Dismal Forecast

The Q2 2025 financial report presented solid fundamental results but was ultimately overshadowed by a disappointing forward outlook.

  • Total net revenue: RMB 5.22 billion (approx. $728 million)
  • Net income: RMB 1.73 billion (approx. $241.6 million)
  • Total loan facilitation growth: +16.1% year-over-year

The positive figures were quickly negated by management’s guidance, which projects a quarter-over-quarter decline in EPS between 2.7% and 14% for Q3. This pessimistic forecast precipitated a 12% plunge in the share price following the announcement.

Should investors sell immediately? Or is it worth buying 360 Finance?

Substantial Dividend Payout Approaches

Despite the negative price action, shareholders have a substantial capital return to anticipate. The FinTech company has declared a semi-annual cash dividend of $0.38 per ordinary share, or $0.76 per ADS (American Depositary Share). This translates to an attractive annualized dividend yield of 5.22%.

  • Ex-dividend date: September 8, 2025
  • Payment date for ordinary shares: September 25, 2025
  • Approximate payment date for ADS: September 30, 2025

This consistent return of capital to investors highlights the company’s continued ability to generate robust cash flows.

Divergent Views from Analysts

Market experts are divided on the stock’s prospects. JPMorgan maintains a bullish “Overweight” rating with a $65 price target. In contrast, Wall Street Zen recently downgraded its recommendation from “Buy” to “Hold.” The consensus price target stands at $51.73, suggesting significant potential upside from current levels, though the weak guidance casts doubt on this optimism.

Institutional Investors Show Discord

Institutional ownership remains high at 74.81% of shares, but recent activity points to significant disagreement among major funds. American Century Investments decreased its stake by 17.8%, while Mirae Asset Global Investments dramatically increased its position by an astounding 10,812.1%. HSBC also sold 23,072 shares. These conflicting moves reflect broader uncertainty regarding the future trajectory of the FinTech sector.

The central question for investors is whether the appeal of the high dividend yield will be enough to offset concerns driven by the company’s gloomy earnings forecast.

Ad

360 Finance Stock: Buy or Sell?! New 360 Finance Analysis from October 18 delivers the answer:

The latest 360 Finance figures speak for themselves: Urgent action needed for 360 Finance investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 18.

360 Finance: Buy or sell? Read more here...

Tags: 360 Finance
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Robinhood Stock
Crypto Stocks

Robinhood Shares Experience Dramatic Trading Session

October 18, 2025
Abeona Therapeut. Stock
Analysis

Biotech Firm Abeona Therapeutics Positioned for Significant Growth

October 18, 2025
Rocket Lab USA Stock
Analysis

Institutional Investors Flock to Rocket Lab as Space Sector Soars

October 18, 2025
Next Post
Lightwave Logic Stock

Lightwave Logic Shares Exhibit High Volatility Amid Mixed Performance Signals

MSCI World ETF Stock

The Hidden Concentration Risk in a Popular Global ETF

Kopin Stock

Kopin Appoints New Finance Chief Amid Strategic Pivot

Recommended

Formycon Stock

Formycon Stock: Q2 Slump Sparks Investor Skepticism

2 months ago
HIMS stock news

Ohio-based Institutional Investor Strs Ohio Decreases Stake in Hims & Hers Health, Inc.

2 years ago
Finance_ Chart up

Analyst Sarah James Bullish on DocGo with 11 Price Target

2 years ago
Exxon Mobil Stock

Can Exxon Mobil Navigate the Oil Price Downturn?

5 days ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Wall Street’s Stark Divide Over UnitedHealth Shares

Political Pressure Mounts as Trump Targets Weight-Loss Drug Pricing

Intel’s High-Stakes Transformation: Workforce Cuts and Price Hikes Signal Critical Juncture

LeonardoADR Shares Gain Momentum Ahead of Earnings Report

Enterprise Networking Specialist Gains AI-Driven Market Leadership

Autoliv’s Q3 2025 Results: A Critical Test for Investors

Trending

Robinhood Stock
Crypto Stocks

Robinhood Shares Experience Dramatic Trading Session

by Dieter Jaworski
October 18, 2025
0

Friday's trading session delivered a rollercoaster performance for Robinhood Markets, with the stock undergoing a remarkable transformation...

Abeona Therapeut. Stock

Biotech Firm Abeona Therapeutics Positioned for Significant Growth

October 18, 2025
Rocket Lab USA Stock

Institutional Investors Flock to Rocket Lab as Space Sector Soars

October 18, 2025
Unitedhealth Stock

Wall Street’s Stark Divide Over UnitedHealth Shares

October 18, 2025
Eli Lilly and Stock

Political Pressure Mounts as Trump Targets Weight-Loss Drug Pricing

October 18, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Robinhood Shares Experience Dramatic Trading Session
  • Biotech Firm Abeona Therapeutics Positioned for Significant Growth
  • Institutional Investors Flock to Rocket Lab as Space Sector Soars

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com